Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H7Cl |
| Molecular Weight | 126.583 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=CC(Cl)=C1
InChI
InChIKey=OSOUNOBYRMOXQQ-UHFFFAOYSA-N
InChI=1S/C7H7Cl/c1-6-3-2-4-7(8)5-6/h2-5H,1H3
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| (Z)-7-Chloro-3-[(3-chlorophenyl)-methylidene]-4-p-tosyl-3,4-dihydro-2H-1,4-benzoxazine. | 2001 Jun |
|
| 2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors. | 2004 Nov 15 |
|
| N9-benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: synthesis and structure-activity relationships at adenosine A1 and A2A receptors. | 2007 Jul 15 |
|
| Genotoxicity of 2-(3-chlorobenzyloxy)-6-(piperazinyl)pyrazine, a novel 5-hydroxytryptamine2c receptor agonist for the treatment of obesity: role of metabolic activation. | 2007 Jun |
|
| Synthesis and antitubercular activity of quaternized promazine and promethazine derivatives. | 2007 Mar 1 |
|
| 1-(3-Chloro-benz-yl)-5-iodo-indoline-2,3-dione. | 2008 Oct 31 |
|
| 3-(3-Chloro-benz-yl)-1H-isochromen-1-one. | 2008 Sep 27 |
|
| Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib. | 2009 Feb 18 |
|
| Characterization of dasatinib and its structural analogs as CYP3A4 mechanism-based inactivators and the proposed bioactivation pathways. | 2009 Jun |
|
| 3,5-Bis(4-fluoro-phen-yl)-1-phenyl-4,5-dihydro-1H-pyrazole. | 2010 Jul 7 |
|
| Enhancement of hydrophobic interactions and hydrogen bond strength by cooperativity: synthesis, modeling, and molecular dynamics simulations of a congeneric series of thrombin inhibitors. | 2010 Mar 11 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID4052841
Created by
admin on Sat Dec 16 04:18:44 GMT 2023 , Edited by admin on Sat Dec 16 04:18:44 GMT 2023
|
PRIMARY | |||
|
203-580-5
Created by
admin on Sat Dec 16 04:18:44 GMT 2023 , Edited by admin on Sat Dec 16 04:18:44 GMT 2023
|
PRIMARY | |||
|
m3445
Created by
admin on Sat Dec 16 04:18:44 GMT 2023 , Edited by admin on Sat Dec 16 04:18:44 GMT 2023
|
PRIMARY | Merck Index | ||
|
7931
Created by
admin on Sat Dec 16 04:18:44 GMT 2023 , Edited by admin on Sat Dec 16 04:18:44 GMT 2023
|
PRIMARY | |||
|
108-41-8
Created by
admin on Sat Dec 16 04:18:44 GMT 2023 , Edited by admin on Sat Dec 16 04:18:44 GMT 2023
|
PRIMARY | |||
|
C499988
Created by
admin on Sat Dec 16 04:18:44 GMT 2023 , Edited by admin on Sat Dec 16 04:18:44 GMT 2023
|
PRIMARY | |||
|
5K8172K9TT
Created by
admin on Sat Dec 16 04:18:44 GMT 2023 , Edited by admin on Sat Dec 16 04:18:44 GMT 2023
|
PRIMARY | |||
|
8767
Created by
admin on Sat Dec 16 04:18:44 GMT 2023 , Edited by admin on Sat Dec 16 04:18:44 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
